Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

0.36USD
19 Feb 2019
Change (% chg)

-- (--)
Prev Close
$0.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
163,414
52-wk High
$3.30
52-wk Low
$0.27

Chart for

About

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. The Company focuses on identifying, developing and commercializing differentiated products that address unmet medical needs. It focuses on underserved therapeutic areas, such as central nervous system (CNS), including neurology and psychiatry, as well as... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $5.24
Shares Outstanding(Mil.): 14.51
Dividend: --
Yield (%): --

Financials

  PTX.OQ Industry Sector
P/E (TTM): -- 32.70 36.06
EPS (TTM): -6.39 -- --
ROI: -61.78 13.12 12.72
ROE: -- 14.12 13.74

Drugmaker Pernix lines up $76 mln offer to sell itself in Chapter 11

Bankrupt drugmaker Pernix Therapeutics Holdings Inc said on Tuesday it had received a stalking-horse bid of nearly $76 million from debt holder Highbridge Capital Management LP as it prepares to sell itself.

Feb 19 2019

Earnings vs. Estimates